Biotech - Press Releases

Date	Title	Company
28-Sep-2020	Minasolve launches three antimicrobial solutions developed with bio-based Caprylyl Glycol	Andrew Lloyd Associates
28-Sep-2020	Single Cell Sequencing Market Size is Worth USD 3,230.6 Million by 2027 \| CAGR of 13.9%: Emergen Research	Emergen Research
28-Sep-2020	Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion	Inceptua Group
28-Sep-2020	Two-Year Data of Evrysdi™ (risdiplam) in Infants with Spinal Muscular Atrophy Demonstrate Continued Improvement of Developmental Milestones	PTC Therapeutics, Inc.
28-Sep-2020	Kymos and Prolytic merge to become Kymos Group, a top pan-European CRO dedicated to innovative pharmaceuticals	Andrew Lloyd Associates
28-Sep-2020	Enesi Pharma Appoints Vaccine Development Expert Dr Keith Howard as Chief Scientific Officer to Lead Research & Development of Novel ImplaVax® Solid-dose, Needle-free Vaccination Products	Enesi Pharma
28-Sep-2020	Phosphine Ligands Now Accessible at Alfa Chemistry Catalysts	Alfa Chemistry Catalysts
28-Sep-2020	Alfa Chemistry Testing Lab Publishes Whitepapers for Varieties of Analytical Testing Services	Alfa Chemistry Testing Lab
28-Sep-2020	Protheragen Launches Intermediary Services for Biotechnology and Drug R&D Companies	Protheragen
28-Sep-2020	TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Injection) ORIENT-32 Study Met Its Primary Endpoints of Progression-Free Survival and Overall Survival in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma (HCC)	Innovent Biologics, Inc.
28-Sep-2020	TYVYT® (Sintilimab Injection) in Combination with BYVASDA® (Bevacizumab Injection) ORIENT-32 Study Met Its Primary Endpoints of Progression-Free Survival and Overall Survival in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma (HCC)	Innovent Biologics, Inc.
27-Sep-2020	InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures	InventisBio Shanghai Limited
27-Sep-2020	InventisBio Announces $147 Million Series D Financing Led by Hillhouse Affiliate GL Ventures	InventisBio Shanghai Limited
25-Sep-2020	FDA Approves First Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years	U.S. Food and Drug Administration
25-Sep-2020	Novo Seeds Portfolio Company Galecto Raises USD 64 Million to Accelerate Development of Clinical Pipeline	Novo Holdings
25-Sep-2020	PharmiWeb.Jobs welcomes Medella Life	Medella Life
25-Sep-2020	Newlight Technologies' AirCarbon Material has been certified carbon negative by the Carbon Trust	Newlight Technologies
25-Sep-2020	Radius Health & Menarini Group Provide Elacestrant Update	Menarini I.F.R.
25-Sep-2020	Dutch Amarna Therapeutics enters research collaboration with Spanish FPS, examining the efficacy of its SV40-based SVec™ gene delivery vector platform technology in diabetes mellitus type 1 and multiple sclerosis	Amarna Therapeutics
25-Sep-2020	Neurophth Therapeutics' Treatment of Leber's Hereditary Optic Neuropathy Gene Therapy NR082 was Granted Orphan Drug Designation by U.S. FDA	Neurophth Therapeutics, Inc.